2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35568074 | Anlotinib combined with the PD-L1 blockade exerts the potent anti-tumor immunity in renal cancer treatment. | 2022 Aug 1 | 1 |
| 2 | 34692475 | Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study. | 2021 | 1 |